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Budget, Authorization, and Appropriations Processes
While recognizing that ASHG membership is international and
global in scope, this article focuses on U.S. Congressional pro-
cesses, in which a majority of our members are heavily invested
because of National Institutes of Health (NIH) funding. We plan
to have an article at a later time on the major funding mecha-
nisms of our international members, because all processes are
crucial as our collaborative projects grow in size and complexity.
General Process
The U.S. federal budget process involves the President proposing
a budget in February and then authorizing committees and pro-
cesses in the Congress to approve (or amend) that budget. But it
is not until the Appropriations Committees settle on the funding
that awards are actually made to the agencies. These Congres-
sional steps should be completed before the federal ﬁscal year
begins in October, but it often happens that Congress cannot
come to an agreement, so the Congress must pass a “continuing
resolution” (CR) that maintains ongoing funding of the federal
agencies at the level of the current year. Without the CR process,
the federal governmental agencies would shut down.
Authorization
In addition to budgetary authority, each federal agency is required
to be periodically reviewed and its very existence authorized. The
NIH had not been reauthorized since 1993 and was several (11)
years past due. Over the past 2 years, there has been much debate
about this reauthorization process, with suggestions about major
changes in the structure of the agency, as well as consolidation
of additional authority in the ofﬁce of the Director. The prevailing
sense has been that, although the NIH is a complicated behe-
moth, the structure of Institutes and Centers (ICs), the general
intramural/extramural relationship, and the peer review process
were not in disarray. After much debate, at 1:32 A.M. onDecember
9, 2006, the NIH Reauthorization Bill was passed, and it was
signed into law by the President on January 9, 2007.
Major points of interest to the human genetics community
include:
● Formal authorization of the National Human Genome Re-
search Institute (NHGRI) as an Institute rather than a Center.
● Establishment of an agencywide reporting system to be put
in place instead of institute-by-institute reporting.
● Creation of a new division in the Ofﬁce of the Director, called
the “Ofﬁce of Planning and Strategic Initiatives” (OPASI),
which will be headed by Dr. Lawrence Krensky.
● Formalization of the Common Fund and a Council of Coun-
cils made up of members of individual Institute Advisory
Councils. The Common Fund may account for up to 5% of
the overall NIH budget and is to serve as an incubator for
cross-cutting initiatives.
● Establishment of a formal public process to assess and deter-
mine structural changes in NIH at least every 7 years.
● Creation of a program of Demonstration Projects in “Bridging
the Science” among agencies and “High Risk, High Reward”
programs.
NIH Appropriations for Fiscal Year 2007
Because the federal ﬁscal year begins on October 1, ﬁscal year
2007 (FY07) actually started on October 1, 2006. Therefore, the
FY07 appropriations process should have been completed by the
last Congress in the early fall. They failed to accomplish that goal,
requiring the passage of CRs, as previously described, to permit
the agencies to continue to operate at the FY06 level. For the
working scientist, that was not egregious, because the FY06 levels
for NIH were, in fact, higher than the levels initially proposed
for FY07.
Subsequently, the scientiﬁc community has worked diligently
with key legislators to increase the budget over the proposed FY07
levels. We thank all of you who responded to the FASEB alerts
and wrote to Congressional leaders at key moments of negotia-
tion. In total, over 7,000 letters were received from scientists. On
February 14, the Joint Funding Resolution was passed and ap-
propriated funding as follows:
NIH $28.93 billion 2% increase over FY06
National Science Foundation $5.92 billion 6% increase over FY06
Veterans Affairs (Medical
Research) $412 million Same as FY06
Department of Energy (Ofﬁce
of Science) $3.79 billion 5.6% increase over FY06
The NIH budget included a total increase of $620 million over
FY06. We owe a debt of gratitude to Congressional stalwarts—
including Senators Specter, Harkin, and Kennedy, as well as the
House leadership—for their continuing effort on behalf of the
biomedical research community.
Our work is only beginning for the FY08 process and beyond.
We must be consistent in our message: biomedical research fund-
ing is an investment in the future health and economic well-
being of the country.
The Future
The President has proposed an NIH budget for FY08 of $28.62
billion (a 0.8% increase from his early assumption of $28.39 bil-
lion for FY07). Because this proposal is well below the currently
authorized level, the scientiﬁc community must inform the leg-
islators that we must focus on the future. For the Congressional
authorization and appropriations debates, FASEB is proposing
6.7% increases for FY08, FY09, and FY10, so that the budget will
allow NIH to recover all the purchasing power it has lost since
the doubling of the NIH budget was completed in 2003.
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We must continue education of our elected ofﬁcials from the
local constituent perspective that additional investment in bio-
medical research will be returned in health and well-being.
ASHG works very closely with the FASEB Ofﬁce of Public Affairs
in enhancing the ﬂow of information from the Hill. As we move
through this Congressional process, you may stay apprised of ac-
tions of the Congress by logging on to the FASEB Web site and
reading theWashington Update provided biweekly while Congress
is in session (http://opa.faseb.org/pages/Washingtonupdate/).
We will use the blast e-mail process only at crucial times of de-
cision making in Washington, so that we remain efﬁcient in us-
ing our collective voice. However, any additional education that
can be accomplished, locally or in Washington, is obviously
appreciated.
Although this federal maze seems daunting, it is critical to be
familiar with the process in order to speak out effectively on
behalf of support for research. If I can be of assistance in visits
to the Hill or in other ways, please do not hesitate to contact me
at jboughman@ashg.org
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